2021
DOI: 10.6061/clinics/2021/e2728
|View full text |Cite
|
Sign up to set email alerts
|

Statistical analysis for efficacy of tirofiban combined with ozagrel in the treatment of progressive cerebral infarction patients out of thrombolytic therapy time window

Abstract: Zhang H, Zheng L. Statistical analysis for efficacy of tirofiban combined with ozagrel in the treatment of progressive cerebral infarction patients out of thrombolytic therapy time window. Clinics (Sao Paulo).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(2 citation statements)
references
References 30 publications
(27 reference statements)
0
2
0
Order By: Relevance
“…A total of 80 patients with ischemic stroke who were hospitalized in Zhoushan Hospital from October 2019 to May 2022 were included in the study, including 40 patients with PCI and 40 patients with NPCI. The inclusion criteria were as follows: (1) patients admitted to the Acute Stroke Unit within 24 h of CI onset; (2) age ≥18 years with no previous stroke history; (3) PCI was defined as the neurological deficits that did not show any improvement and continued to progress within 1 week under regular treatment, with the NIHSS score increased by at least 2 points 13,14 . The exclusion criteria were as follows: (1) patients with severe impairment of consciousness, transient ischemic attack, hemorrhagic stroke, subarachnoid hemorrhage, intracranial infection, intracranial hemorrhage, intracranial tumor, trauma, or neurodegenerative disease; (2) severe cardiac, hepatic, and renal insufficiency; (3) comorbid hematologic disease, malignancy, autoimmune disease; (4) more than two consecutive BP recordings missing (i.e., with any interval more than 4 h between recordings).…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…A total of 80 patients with ischemic stroke who were hospitalized in Zhoushan Hospital from October 2019 to May 2022 were included in the study, including 40 patients with PCI and 40 patients with NPCI. The inclusion criteria were as follows: (1) patients admitted to the Acute Stroke Unit within 24 h of CI onset; (2) age ≥18 years with no previous stroke history; (3) PCI was defined as the neurological deficits that did not show any improvement and continued to progress within 1 week under regular treatment, with the NIHSS score increased by at least 2 points 13,14 . The exclusion criteria were as follows: (1) patients with severe impairment of consciousness, transient ischemic attack, hemorrhagic stroke, subarachnoid hemorrhage, intracranial infection, intracranial hemorrhage, intracranial tumor, trauma, or neurodegenerative disease; (2) severe cardiac, hepatic, and renal insufficiency; (3) comorbid hematologic disease, malignancy, autoimmune disease; (4) more than two consecutive BP recordings missing (i.e., with any interval more than 4 h between recordings).…”
Section: Methodsmentioning
confidence: 99%
“…(3) PCI was defined as the neurological deficits that did not show any improvement and continued to progress within 1 week under regular treatment, with the NIHSS score increased by at least 2 points. 13,14 The exclusion criteria were as follows: (…”
mentioning
confidence: 99%